Infection Risks and Antibiotic Stewardship in CAR T-Cell Therapy
Archives of Biomedical Research · 31.12.2025 · 1 (1) · 27
DOI: 10.33696/biomedicalresearch.1.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biomedical Research, online erschienen am 31.12.2025. Verfasst von Yusuf Ishaya Dogonzo. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the management of refractory hematologic malignancies such as leukemia, lymphoma and multiple myeloma, offering unprecedented remission rates. Yet, complications arising from infections remain a major challenge, particularly in the early post-infusion period and during prolonged immune suppression. This editorial synthesizes recent evidence (2021–2025) on infection epidemiology, risk factors, and stewardship strategies in CAR T-cell recipients. Early infections, especially from bacteria are influenced by neutropenia, prior therapy, and disease biology, while long-term immune suppression of CD4+ T cells help sustain vulnerability. Antibiotic stewardship presents a critical opportunity to reduce unnecessary exposure through biomarker-guided diagnostics and de-escalation protocols. Rising cases of antimicrobial resistance and dysbiosis pose significant challenges, while emerging diagnostic technologies and microbiome-focused interventions offer promise. Future strategies should be focused on integrating clinical vigilance, harmonized prophylaxis, and microbiome-awareness stewardship to optimize both safety and efficacy in CAR T-cell therapy.
Zitieren
APA
Dogonzo, Y. I. (2025). Infection Risks and Antibiotic Stewardship in CAR T-Cell Therapy. Archives of Biomedical Research, 1(1), 27. https://doi.org/10.33696/biomedicalresearch.1.005
Vancouver
Dogonzo YI. Infection Risks and Antibiotic Stewardship in CAR T-Cell Therapy. Archives of Biomedical Research. 2025;1(1):27. doi:10.33696/biomedicalresearch.1.005
BibTeX
@article{Dogonzo2025,
author = {Dogonzo, Yusuf Ishaya},
title = {Infection Risks and Antibiotic Stewardship in CAR T-Cell Therapy},
journal = {Archives of Biomedical Research},
year = {2025},
volume = {1},
number = {1},
pages = {27},
doi = {10.33696/biomedicalresearch.1.005}
}
EUVIMED